The Netherlands Cancer Institute
Clinical trials sponsored by The Netherlands Cancer Institute, explained in plain language.
-
New hope for High-Risk breast cancer: immune booster after chemo may keep cancer away
Disease control Not yet recruitingThis phase 3 trial tests whether adding the immunotherapy drug pembrolizumab to standard post-surgery treatment can prevent breast cancer from returning in people with early-stage triple-negative breast cancer who still had cancer after initial chemo and pembrolizumab. About 1000…
Phase: PHASE3 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated May 16, 2026 23:50 UTC
-
New imaging study could unlock secrets of HER2 lung cancer treatment
Knowledge-focused Not yet recruitingThis early-stage study will use a special PET scan to track a targeted drug (trastuzumab) in 20 people with advanced HER2-positive lung cancer. The goal is to see if the drug collects differently in tumors with a HER2 mutation versus those with too much HER2 protein. This is an o…
Phase: PHASE1 • Sponsor: The Netherlands Cancer Institute • Aim: Knowledge-focused
Last updated May 16, 2026 23:47 UTC